Upcoming issues of Medical Writing.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 101
- Publication type:
- Article
Works matching IS 20474806 AND DT 2018 AND VI 27 AND IP 2
Results: 45
1
2
Finding my way in the world of freelancing - in vitro medical devices.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 99
- By:
- Publication type:
- Article
3
Opening up the room.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 97
- By:
- Publication type:
- Article
4
Editorial.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
5
The EMWA Ambassador Programme.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 96
- By:
- Publication type:
- Article
6
Paving the path towards medical writing.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 95
- By:
- Publication type:
- Article
7
Editorial.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 95
- By:
- Publication type:
- Article
8
Medical Devices.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
9
Good Writing Practice.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 91
- By:
- Publication type:
- Article
10
An Introduction to Pharmacovigilance (Second Edition).
- Published in:
- 2018
- By:
- Publication type:
- Book Review
11
Inconsistent reporting between protocols or registrations and full reports of primary biomedical research.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 88
- Publication type:
- Article
12
RCTs published in The BMJ and PLOS Medicine can be reanalysed when authors share data.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 87
- Publication type:
- Article
13
Transparency in authors' contributions and responsibilities.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 87
- Publication type:
- Article
14
Good Practice for Conference Abstracts and Presentations: GP-CAP.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 86
- Publication type:
- Article
15
An interview with Chris Winchester: Chief Executive Officer of HealthScience communications consultancy Oxford PharmaGenesis and a leading member of Open Pharma.
- Published in:
- 2018
- Publication type:
- Interview
16
Creative medical writing: An oxymoron?
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 82
- By:
- Publication type:
- Article
17
Creative medical writing: An oxymoron?
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 81
- By:
- Publication type:
- Article
18
Winners of the Geoff Hall Scholarship Essay Competition.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 80
- By:
- Publication type:
- Article
19
Prostate cancer medicine Xofigo must not be used with Zytiga and prednisone/prednisolone.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 79
- Publication type:
- Article
20
EMA recommends immediate suspension and recall of multiple sclerosis medicine Zinbryta.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 79
- Publication type:
- Article
21
New tracking tool for EMA's relocation to Amsterdam.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 78
- Publication type:
- Article
22
Revised guideline on clinical studies for Alzheimer's disease medicines.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 78
- Publication type:
- Article
23
First-in-class medicine to prevent bleeding in haemophilia A patients with inhibitors.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 76
- Publication type:
- Article
24
President's Message.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 3
- By:
- Publication type:
- Article
25
First medicine to treat neonatal diabetes.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 77
- Publication type:
- Article
26
General Court confirms EMA approach to transparency.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 77
- Publication type:
- Article
27
Harmonising format and style requirements for scientific and medical publications: Time to address a long-pending dream.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 71
- By:
- Publication type:
- Article
28
Preparing clinical study reports for external sharing: how to balance patient privacy/data utility priorities and manage risk.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 68
- By:
- Publication type:
- Article
29
CORE Reference (Clarity and Openness in Reporting: E3-based): - a tool for modern clinical study reports in an era of increasing transparency and disclosure.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 64
- By:
- Publication type:
- Article
30
Why clinical study reports really matter.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 59
- By:
- Publication type:
- Article
31
Lay titles for clinical trials: A balancing act.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 55
- By:
- Publication type:
- Article
32
Writing lay summaries: What medical writers need to know.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 49
- By:
- Publication type:
- Article
33
Clinical data publication by the EMA: The challenges facing the pharmaceutical industry.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 39
- By:
- Publication type:
- Article
34
Clinical trial results disclosure on ClinicalTrials.gov and EudraCT.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 44
- By:
- Publication type:
- Article
35
Policies 0070 and 0043: Juggling different requirements.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 31
- By:
- Publication type:
- Article
36
Preparing anonymisation reports in general and for an orphan drug in particular.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 27
- By:
- Publication type:
- Article
37
The end of a successful pilot. . . GAPP retires after 6 years.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 26
- By:
- Publication type:
- Article
38
Anonymisation reports from 2016 to 2017: A preliminary analysis.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 22
- By:
- Publication type:
- Article
39
Navigating the EMA clinical data website.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 19
- By:
- Publication type:
- Article
40
Clinical trial disclosure and transparency: Regulation EU No. 536/2014 Public disclosure at the clinical trial level.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 7
- By:
- Publication type:
- Article
41
The Regulatory Public Disclosure Special Interest Group.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 6
- By:
- Publication type:
- Article
42
ISMPP U webinar on the Joint Position Statement on the Role of Professional Medical Writers.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 4
- Publication type:
- Article
43
EMWA's webinar series.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 4
- By:
- Publication type:
- Article
44
EMWA News.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 4
- Publication type:
- Article
45
Medical Writing: Public Disclosure.
- Published in:
- Medical Writing, 2018, v. 27, n. 2, p. 1
- By:
- Publication type:
- Article